no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A cost comparison of introducing and delivering pneumococcal, rotavirus and human papillomavirus vaccines in Rwanda
|
Ngabo, Fidèle |
|
2015 |
33 |
51 |
p. 7357-7363 7 p. |
article |
2 |
A cytomegalovirus DNA vaccine induces antibodies that block viral entry into fibroblasts and epithelial cells
|
McVoy, Michael A. |
|
2015 |
33 |
51 |
p. 7328-7336 9 p. |
article |
3 |
Analysis of T cell responses to chimpanzee adenovirus vectors encoding HIV gag–pol–nef antigen
|
Herath, S. |
|
2015 |
33 |
51 |
p. 7283-7289 7 p. |
article |
4 |
Arguments and sources on Italian online forums on childhood vaccinations: Results of a content analysis
|
Fadda, Marta |
|
2015 |
33 |
51 |
p. 7152-7159 8 p. |
article |
5 |
A sera-epidemiological study on pertussis immunity levels among community populations and an analysis of the underlying factors in Tianjin China
|
Zhang, Ying |
|
2015 |
33 |
51 |
p. 7183-7187 5 p. |
article |
6 |
Baseline serum interleukin-6 to interleukin-2 ratio is associated with the response to seasonal trivalent influenza vaccine in solid organ transplant recipients
|
Fernández-Ruiz, Mario |
|
2015 |
33 |
51 |
p. 7176-7182 7 p. |
article |
7 |
Cancer vaccines in the new era of cancer immunotherapy
|
Knutson, Keith L. |
|
2015 |
33 |
51 |
p. 7376- 1 p. |
article |
8 |
Checkpoint blockade in combination with cancer vaccines
|
Morse, Michael A. |
|
2015 |
33 |
51 |
p. 7377-7385 9 p. |
article |
9 |
Combination recombinant simian or chimpanzee adenoviral vectors for vaccine development
|
Cheng, Cheng |
|
2015 |
33 |
51 |
p. 7344-7351 8 p. |
article |
10 |
Community awareness and predictors of uptake of pertussis booster vaccine in South Australian adults
|
Clarke, Michelle |
|
2015 |
33 |
51 |
p. 7337-7343 7 p. |
article |
11 |
Corrigendum to “Evaluation of a Salmonella Enteritidis vaccine and related ELISA for respective induction and assessment of acquired immunity to the vaccine and/or Echinacea purpurea in Awassi Ewes” [Vaccine 33 (2015) 2228–2231]
|
Barbour, Elie K. |
|
2015 |
33 |
51 |
p. 7375- 1 p. |
article |
12 |
Critical issues in cancer vaccine trial design
|
Clifton, Guy T. |
|
2015 |
33 |
51 |
p. 7386-7392 7 p. |
article |
13 |
Cross protection between the first and second waves of the 1918 influenza pandemic among soldiers of the Canadian Expeditionary Force (CEF) in Ontario
|
Bogaert, Kandace |
|
2015 |
33 |
51 |
p. 7232-7238 7 p. |
article |
14 |
Current methods of epitope identification for cancer vaccine design
|
Cherryholmes, Gregory A. |
|
2015 |
33 |
51 |
p. 7408-7414 7 p. |
article |
15 |
Editorial Board/Aims and Scope
|
|
|
2015 |
33 |
51 |
p. IFC- 1 p. |
article |
16 |
Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting
|
Doll, Margaret K. |
|
2015 |
33 |
51 |
p. 7307-7314 8 p. |
article |
17 |
Effect of complement Factor H on anti-FHbp serum bactericidal antibody responses of infant rhesus macaques boosted with a licensed meningococcal serogroup B vaccine
|
Giuntini, Serena |
|
2015 |
33 |
51 |
p. 7168-7175 8 p. |
article |
18 |
Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia
|
Roca, Anna |
|
2015 |
33 |
51 |
p. 7144-7151 8 p. |
article |
19 |
Efficacy of parainfluenza virus 5 (PIV5)-based tuberculosis vaccines in mice
|
Chen, Zhenhai |
|
2015 |
33 |
51 |
p. 7217-7224 8 p. |
article |
20 |
Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine
|
Carignan, Damien |
|
2015 |
33 |
51 |
p. 7245-7253 9 p. |
article |
21 |
116E rotavirus vaccine may have less impact in India than projected
|
Piple, Jiteendra Kumar |
|
2015 |
33 |
51 |
p. 7142- 1 p. |
article |
22 |
Evaluation of rotavirus disease burden and vaccine effectiveness in India
|
Kang, Gagandeep |
|
2015 |
33 |
51 |
p. 7143- 1 p. |
article |
23 |
Evolution of animal models in cancer vaccine development
|
Wei, Wei-Zen |
|
2015 |
33 |
51 |
p. 7401-7407 7 p. |
article |
24 |
Factors affecting the causality assessment of adverse events following immunisation in paediatric clinical trials: An online survey
|
Voysey, Merryn |
|
2015 |
33 |
51 |
p. 7203-7210 8 p. |
article |
25 |
From current vaccine recommendations to everyday practices: An analysis in five sub-Saharan African countries
|
Delrieu, Isabelle |
|
2015 |
33 |
51 |
p. 7290-7298 9 p. |
article |
26 |
Getting the most from the Ebola vaccine success
|
Daniele, Focosi |
|
2015 |
33 |
51 |
p. 7141- 1 p. |
article |
27 |
Identification of biomarkers to measure HIV-specific mucosal and systemic CD8+ T-cell immunity using single cell Fluidigm 48.48 Dynamic arrays
|
Trivedi, Shubhanshi |
|
2015 |
33 |
51 |
p. 7315-7327 13 p. |
article |
28 |
Increasing postpartum rate of vaccination with tetanus, diphtheria, and acellular pertussis vaccine by incorporating pertussis cocooning information into prenatal education for group B streptococcus prevention
|
Cheng, Po-Jen |
|
2015 |
33 |
51 |
p. 7225-7231 7 p. |
article |
29 |
Influenza vaccine effectiveness against hospitalisation with influenza in adults in Australia in 2014
|
Cheng, Allen C. |
|
2015 |
33 |
51 |
p. 7352-7356 5 p. |
article |
30 |
In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment
|
Vanpouille-Box, Claire |
|
2015 |
33 |
51 |
p. 7415-7422 8 p. |
article |
31 |
Novel CD8+ cytotoxic T cell epitopes in bovine leukemia virus with cattle
|
Bai, Lanlan |
|
2015 |
33 |
51 |
p. 7194-7202 9 p. |
article |
32 |
Phenotypic characterization of bovine memory cells responding to mycobacteria in IFNγ enzyme linked immunospot assays
|
Blunt, Laura |
|
2015 |
33 |
51 |
p. 7276-7282 7 p. |
article |
33 |
Public opinion on childhood immunisations in Iceland
|
Óskarsson, Ýmir |
|
2015 |
33 |
51 |
p. 7211-7216 6 p. |
article |
34 |
Response to pneumococcal polysaccharide vaccination in patients with chronic and allergic aspergillosis
|
Kosmidis, Chris |
|
2015 |
33 |
51 |
p. 7271-7275 5 p. |
article |
35 |
RT-qPCR-based microneutralization assay for human cytomegalovirus using fibroblasts and epithelial cells
|
Wang, Xiao |
|
2015 |
33 |
51 |
p. 7254-7261 8 p. |
article |
36 |
Safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50–64 years of age
|
DiazGranados, Carlos A. |
|
2015 |
33 |
51 |
p. 7188-7193 6 p. |
article |
37 |
Safety and immunogenicity of ricin vaccine, RVEc™, in a Phase 1 clinical trial
|
Pittman, Phillip R. |
|
2015 |
33 |
51 |
p. 7299-7306 8 p. |
article |
38 |
Successful cross-protective efficacy induced by heat-adapted live attenuated nephropathogenic infectious bronchitis virus derived from a natural recombinant strain
|
Lim, Tae-Hyun |
|
2015 |
33 |
51 |
p. 7370-7374 5 p. |
article |
39 |
Superior protection elicited by live-attenuated vaccines in the murine model of paratuberculosis
|
Ghosh, Pallab |
|
2015 |
33 |
51 |
p. 7262-7270 9 p. |
article |
40 |
Suppression of T cell responses in the tumor microenvironment
|
Frey, Alan B. |
|
2015 |
33 |
51 |
p. 7393-7400 8 p. |
article |
41 |
The effectiveness of influenza vaccination in preventing hospitalisation in children in Western Australia
|
Blyth, Christopher C. |
|
2015 |
33 |
51 |
p. 7239-7244 6 p. |
article |
42 |
The incidence of childhood and adolescent seizures in the UK from 1999 to 2011: A retrospective cohort study using the Clinical Practice Research Datalink
|
Sammon, Cormac J. |
|
2015 |
33 |
51 |
p. 7364-7369 6 p. |
article |
43 |
Vaccine-associated reduction in symptom severity among patients with influenza A/H3N2 disease
|
Deiss, Robert G. |
|
2015 |
33 |
51 |
p. 7160-7167 8 p. |
article |